Publication:
Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Placeholder

Organizational Units

Program

KU-Authors

KU Authors

Co-Authors

Ormeci, Asli
Aydin, Yucel
Sumnu, Abdullah
Soyer, Ozlem Mutluay
Pinarbasi, Binnur
Gokturk, Suut
Gulluoglu, Mine
Onel, Derya
Badur, Selim
Akyuz, Filiz

Advisor

Publication Date

Language

English

Journal Title

Journal ISSN

Volume Title

Abstract

Objectives: Serum alanine aminotransferase (ALT) is a controversial marker for disease monitoring in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. The aim of this study was to determine the fibrosis stage and histological activity index (HAI) in HBeAg-negative CHB patients with persistently normal ALT (PNALT) and high serum HBV DNA (>= 2000 IU/ml) and to investigate clinical risk factors for the requirement of treatment through the examination of liver biopsy specimens.

Description

Source:

International Journal of Infectious Diseases

Publisher:

Elsevier Sci Ltd

Keywords:

Subject

Infectious diseases

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

0

Downloads

View PlumX Details